Vivos (RDGL) Short term Debt (2011 - 2023)
Vivos recorded quarterly Short term Debt of $10000.0 in Q3 2023, down 99.97% quarter-over-quarter from $30.1 million in Q3 2018.
Vivos' Short term Debt history runs 9 years deep, the most recent figure standing at $10000.0 for Q3 2023.
- In Q3 2023, Short term Debt changed N/A year-over-year to $10000.0; the TTM figure through Sep 2023 stood at $10000.0 (changed N/A YoY), while the FY2016 annual figure was $324532.0, down 92.34% from the prior year.
- Short term Debt came in at $10000.0 for Q3 2023 at Vivos, down from $30.1 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $10000.0 in Q3 2023 to a low of $10000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2018 | 30.06 Mn |
| Jun 30, 2018 | 5.23 Mn |
| Mar 31, 2018 | 40,000.00 |
| Sep 30, 2017 | 383,771.00 |
| Jun 30, 2017 | 383,771.00 |
| Mar 31, 2017 | 383,771.00 |
| Dec 31, 2016 | 324,532.00 |
| Sep 30, 2016 | 332,195.00 |
| Jun 30, 2016 | 1.26 Mn |
| Mar 31, 2016 | 1.33 Mn |
| Dec 31, 2015 | 4.24 Mn |
| Sep 30, 2015 | 2.72 Mn |
| Jun 30, 2015 | 195,500.00 |
| Mar 31, 2015 | 9.19 Mn |
| Dec 31, 2014 | 4.43 Mn |
| Sep 30, 2014 | 512,094.00 |
| Jun 30, 2014 | 2.13 Mn |
| Mar 31, 2014 | 485,402.00 |
| Dec 31, 2013 | 349,913.00 |
| Sep 30, 2013 | 1.39 Mn |
| Jun 30, 2013 | 1.33 Mn |
| Dec 31, 2012 | 35,846.00 |
| Sep 30, 2012 | 33,086.00 |
| Jun 30, 2012 | 105,000.00 |
| Mar 31, 2012 | 161,000.00 |
| Jun 30, 2011 | 55,000.00 |